Back to School 2020
McMurry-Heath: COVID-19 raises stakes for industry to take the lead on promoting science: a BioCentury audio interview
BIO CEO McMurry-Heath says industry will be judged on how it addresses racial disparities and ensures access for all patients
BIO CEO Michelle McMurry-Heath says industry will be judged on how it addresses racial disparities and ensures access for all patients.
Michelle McMurry-Heath, three months into her role as president and CEO of BIO, sees the pandemic as a crucial time for the biopharma industry to tell its story better to the public, and ensure its foundation of science is both understood and used to benefit all everyone.
In a Back to School interview, McMurry-Heath discussed the lessons she thinks the industry can learn from its response to COVID-19. The conversation was one in a series of interviews with industry leaders for BioCentury’s Back to School 2020 package (see Cover Story: “The Imperative of COVID-19”).
The biotech industry’s mobilization against COVID-19 has not immunized it from criticism, and a big part of McMurry-Heath’s job is persuading the public that BIO’s companies are on their side. “We're still facing these really reductionist attempts to